GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Notes on Pharming Group, n.v.

[Added 4Q07 results and IP license from ACTC.]

#msg-26347101 Pharming appeals EMEA rejection, reiterates US plans
#msg-25275659 EMEA rejects Rhucin for HAE
#msg-22208171 Phase-3 Rhucin data
#msg-22482530 Pharming seeks US Rhucin partner

#msg-26844990 4Q07 results
#msg-20830051 Pipeline overview

#msg-18949245 IP cross-license with GTC
#msg-27220955 Pharming licenses cattle IP from ACTC